Mylan’s grace period for EpiPen rebates could cost Medicaid up to $120 million.
cnb.cx/2e79dTL Via @_DanMangan @CNBC
posted on October 11, 2016 by
Medicaid, Medicare, Health Reform Consultant, Speaker, Author
Mylan’sgrace period for EpiPen rebates could cost…
<span class="my_class">Piper</span> Report
- Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory Models
- Use of Prescription Medicines Today and Forecasts for 2023: Valuable Market Insights from IQVIA
- Real-World Evidence in Medical Product Development: Drugs, Biologics, Diagnostics, and Devices
- Physician Practice Patterns and Perspectives on Change: Insights from National Survey
- Teen Hospital Stays for Childbirth: Latest National and State Specific Trends
- Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid, Medicare Part D, and Private Health Insurance